Nicholas has extensive experience in issues arising out of the financial crisis, including a range of issues relating to residential mortgage backed securities (“RMBS”) and lending practices. He has represented issuers and sponsors of RMBS in fraud and breach of contract cases, as well as federal and state securities actions. Nicholas has defended a global financial institution in connection with two separate trials in the New York Supreme Court.
Nicholas is a key member of the Orrick team that represents Goldman Sachs and Credit Suisse, multinational investment banks and financial services companies, in connection with more than a dozen cases. This includes defending the clients against claims brought by investors, trustees, and monoline insurance companies in connection with the purchase and sale of RMBS. Nicholas also completed a secondment at Credit Suisse, where he was in the litigation and investigations group. During this time, he worked on regulatory matters involving FINRA, the SEC, the DOJ, the CFTC, and the NY Department of Financial Services. Additionally, he handled internal investigations addressing issues such as insider trading.
Nicholas also represents creditors in connection with insolvency-related litigation, including financial institutions and pharmaceutical companies. Nicholas recently helped spearhead a successful litigation strategy that resulted in the acquisition of a life-saving drug program on behalf of a global biopharmaceutical development company.
Nicholas has also represented one of the nation’s largest mortgage loan servicers. This engagement covers all of the company’s RMBS related legal issues. Nicholas has also represented this company in a class action lawsuit involving allegations of improper loan servicing practices.
Nicholas' experience includes: